Urinary Frequency clinical trials at UC Irvine
1 research study open to eligible people
open to eligible females ages 18 years and up
Patients with either overactive bladder (OAB) or urgency urinary incontinence (UUI) with be randomized (like a flip of a coin) to receive 100 units of bladder Botox® at either one injection site or ten injection sites. Efficacy and patient satisfaction will be measured by questionnaires.
Our lead scientists for Urinary Frequency research studies include Felicia Lane, MD.